Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

1861 - 1870 of 57753 results found

An Oral Interleukin-23-Receptor Antagonist Peptide for Plaque Psoriasis

Date
Wednesday, February 07, 2024 - 4:00 AM
Description
CONCLUSIONS: After 16 weeks of once- or twice-daily oral administration, treatment with the interleukin-23-receptor antagonist peptide JNJ-77242113 showed greater efficacy than placebo in patients with moderate-to-severe plaque psoriasis. (Funded by

Autoimmunity and long COVID in children

Date
Wednesday, February 07, 2024 - 4:00 AM
Description
Numerous hypotheses regarding the pathogenetic mechanisms of long COVID have been proposed. Immune dysregulation and autoimmunity are among the leading hypotheses. In this article, we present two clinical cases of long COVID. The first case